| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $310.59M | - | |
| COO | 473.3K | $38.76M | - | |
| Other | 227.0K | $18.59M | - | |
| CFO | 162.9K | $13.34M | - | |
| Dir | 123.1K | $10.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 141,122 | $10.87 | $1,533,336.57 | -0.7% | +60.0% | +452.5% | |
| Mar 13, 2025 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 51,425 | $15.07 | $774,974.75 | -1.3% | +11.1% | +265.3% | |
| Mar 4, 2025 | Anzalone Christopher Richard60 | Chief Executive Officer | Sale+OE | 300,000 | $17.58 | $5,274,333.67 | -3.8% | -4.1% | +280.5% | |
| Jan 23, 2025 | Olukotun Adeoye Y52 | Director | Sell | 959 | $21.00 | $20,139.00 | -2.6% | -39.6% | +211.4% | |
| Jan 7, 2025 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sell | 45,167 | $19.77 | $893,095.40 | -2.3% | -47.9% | +234.0% | |
| Jan 7, 2025 | O'Brien Patrick76 | COO And General Counsel | Sell | 37,184 | $19.80 | $736,058.62 | -2.3% | -47.9% | +234.0% | |
| Jan 6, 2025 | Hamilton James C72 | Chief Discovery/ Trans Medicine | Sell | 32,729 | $19.82 | $648,824.25 | -5.6% | -47.4% | +263.1% | |
| Jan 2, 2025 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 11,520 | $19.05 | $219,456.00 | -0.3% | -35.4% | +245.0% | |
| Dec 27, 2024 | Olukotun Adeoye Y52 | Director | Sell | 2,850 | $20.00 | $57,000.00 | -7.2% | -27.2% | +270.0% | |
| Dec 23, 2024 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 12,563 | $19.59 | $246,109.17 | -0.3% | -21.5% | +253.6% |